Epidemiological reports describe a strong association between prenatal human influenza viral infection and later development of schizophrenia. Postmodern human brain studies, however, indicate a lack of gliosis in schizophrenic brains presumably secondary to absence of glial cells during the second trimester viral infection in utero. We hypothesized that human influenza infection in day 9 pregnant mice would alter the expression of glial fibrillary acidic protein (GFAP, an important marker of gliosis, neuron migration, and reactive injury) in developing brains of postnatal days 0, 14 and 35 mice. Determination of cellular GFAP immunoreactivity (IR) expressed as cell density in cortex and hippocampus of control and experimental brains showed increases in GFAP-positive density in exposed cortical (P = 0.03 day 14 vs control) and hippocampal cells (P = 0.035 day 14, P = 0.034 day 35). Similarly, ependymal cell layer GFAP-IR cell counts showed increases with increasing brain age from day 0, to days 14 and 35 in infected groups (P = 0.037, day 14) vs controls. The GFAP-positive cells in prenatally exposed brains showed 'hypertrophy' and more stellate morphology. These results implicate a significant role of prenatal human influenza viral infection on subsequent gliosis, which persists throughout brain development in mice from birth to adolescence.
Introduction
Schizophrenia is a neurodevelopmental disorder of the brain, which affects multiple brain areas causing significant pathology. The affected individual begins to exhibit symptoms of the illness ie, delusions, hallucinations, disorganized speech and/or behavior, loss of volition, and poverty of thought during adolescence or young adulthood. 1 There is robust evidence to support a genetic etiology for the majority of schizophrenia cases. 2 Alternatively, nonfamilial forms of schizophrenia appear to be caused by certain environmental insults to the growing brain. 3 These insults include prenatal human influenza viral infection, 4 Rh incompatibility 5 and famine. 6 A large body of epidemiologic evidence points to prenatal human influenza viral infection during the second trimester of pregnancy. 3 There is, however, limited experimental data linking a viral etiology to genesis of schizophrenia. 4 We have previously shown that prenatal human influenza infection on day 9 of pregnancy caused alterations in several important brain markers in day 0 neonatal brains. [7] [8] [9] Thus, viral infection in utero caused increases in hippocampal SNAP-25 7 and nNOS 8 levels while reducing the Reelin immunoreactivity in hippocampus and cortex. 9 Additionally, prenatal viral infection caused decreases in neocortical and hippocampal thickness. 9 An important postmortem finding in brains of schizophrenic patients 10 is absence of gliosis. However, few recent studies point to potential increases in gliosis in a subpopulation of schizophrenic patients. 11, 12 We, thus hypothesized that human influenza viral infection in day 9 pregnant mice may alter the expression of glial fibrillary acidic protein (GFAP), an important universal marker of gliosis and astrocytic reaction to injury. Here we use GFAP immunocytochemistry to examine the time course of brain response to a prenatal human influenza viral insult.
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Materials and methods
Animals and viral infection
The protocol reported previously was used. [7] [8] [9] All animal experiments were performed following IRB approval and in accordance with institutional animal care and use committee guidelines at Utah State University and University of Minnesota. Briefly, pregnant C57BL/6 mice were exposed to influenza A/NWS/33 (H1N1) or vehicle, following determination of a viral dosage, which caused sublethal lung and upper respiratory infection. Pregnant infected mice survived the infection.
Immunohistochemistry
Pregnant mice were allowed to deliver pups. The day of delivery was considered day 0. Groups of infected (n = 3 (day 0), n = 3 (day 14), n = 3 (day 35)) and shaminfected newborns (n = 3 (day 0), n = 3 (day 14), n = 2 (day 35)) were deeply anesthetized using Ketamine (167 mg kg −1 IP, Phoenix Scientific, St Joseph, MO, USA). Brains were removed from skull cavities and immersed in phosphate-buffered 4% paraformaldehyde (pH 7.4) for 7-14 days at 4°C. Following cryopreservation in 30% sucrose, coronal sections (10 m) were cut on an IEC-minitome cryostat (IEC, Needham Heights, MA, USA) and placed on subbed slides. All infected and sham-infected sections of the cortex and hippocampus were level-matched using the atlas of embryonic 13 and adult mouse brain. 14 Sections were taken from a minimum of three levels of cortex and hippocampus in experimental and control mice. Sections were warmed to room temperature (RT), dried, post-fixed in acetone for 10 min and redried at RT; they were subsequently washed three times at RT in phosphate-buffered saline containing 0.2% Triton X-100 (TX-100) (PBS, 10 mM sodium phosphate, 150 mM NaCl, pH 7.4). Later, sections were immersed for 30 min at RT in PBS containing 0.2% Triton X-100 and 3% normal goat serum. The sections were incubated with the following antibody: mouse anti-GFAP monoclonal antibody, 1:400 (Sigma, St Louis, MO, USA). Following a 48-h incubation with primary antibody at 4°C and multiple washes in PBS-TX-100 (0.2%), 5 nm gold-conjugated goat antimouse IgG (Goldmark, NJ, USA) was added to the slides at a dilution of 1:100 for 1 h at RT. Subsequently, silver (Goldmark) enhancement was carried out on all slides, including control sections (without primary antibody) at a ratio of 1:1 of developer and enhancer for 17-25 min at RT. Reaction times for silver deposition were always identical in control and infected brain sections. The reactions were terminated by washing the slides with distilled water. Slides were then dehydrated through a graded alcohol series and xylene and coverslipped in permount before examination with a Nikon Labophot-2 microscope (Fryer, Bloomington, MN, USA) under bright light field.
Detection of viral antigenicity by immunocytochemistry
For detection of human influenza viral antigens, control and exposed mouse brain sections from day 0, day 14 and day 35 groups were processed as follows: sections were warmed to room temperature and hydrated in PBS for 5 min. Later, slides were quenched in 0.09% H 2 O 2 in methanol for 30 min at RT, then washed three times (5 min each) in PBS. Three primary antibodies were used in independent experiments: monoclonal mouse anti influenza A (1:500 dilution, Chemicon, Temicula, CA, MAB#8252), polyclonal goat anti influenza A (1:500 dilution, Chemicon, AB#1074) and monoclonal mouse anti influenza A antibody (50 l per slide, Bartel's, B1029-87B).
Following inclusion of positive control slides (Chemicon influenza A&B control slides 5010-5; VRK antigen control slides including parainfluenza 1,2,3, RSV, Adenovirus, influenza A, influenza B, Bartel's B1029-86D), all slides were incubated in a humid chamber for 24 h at 4°C. Later, slides were drained and washed in PBS (3 × 5 min) and treated with appropriate secondary antibody treatments for 30 min at RT. Following three washes (5 min) in PBS, ABC solution (Vector, Burlingame, CA, USA) was applied and slides incubated for 30 min at RT. Finally, slides were washed in PBS (2 × 5 min) and developed in DAB solution (SK-4100 kit, Vector) for 8 min. Later slides were washed in distilled H 2 O (2 × 5 min) and subjected to dehydration steps as described above and coverslipped in permount before examination under a microscope.
Viral culture assay
To assay for presence of virus in the brains of exposed mice, brains (n = 3 day 1, n = 2, 6-week-old) and lung tissues (6-week-old exposed mice) were homogenized to a 10% w/v suspension in Minimum Essential Medium (MEM) and ten-fold dilutions ranging from 10 0 to 10 −6 were added to triplicate wells in flat-bottomed microplates containing an 18-h monolayer of MDCK cells. Medium bathing the cells consisted of MEM including 0.18% NaHCO 3 , 20 g EDTA ml −1 and 50 g gentamicin ml
. The plates were sealed and incubated in a humidified atmosphere at 37°C for 3 days, after which they were examined microscopically for development of influenza viral cytopathic effect (CPE).
To confirm the absence of influenza virus in the cells, they were then drained of medium, rinsed with PBS, fixed with acetone, rinsed again with PBS, then stained with fluoresin-conjugated monoclonal antibody against influenza A virus (Light Diagnostics #5017 Influenza A MAB:FITC, Chemicon, Temicula, CA, USA). As controls, a slide accompanying this antibody containing both influenza A-positive and -negative wells was similarly stained. The slide and plates were incubated at 37°C for 30 min in a humidified incubator and then rinsed with PBS/Tween and observed under a Nikon 'TMD-EF' inverted microscope with a B-1A filter cassette in place.
Cell counting and area measurements GFAP-positive cells were counted by one individual blinded to the nature of slides and cells were counted based on immunostaining and morphology ( Figure 1 ).
Figure 1
Coronal cortical and hippocampal sections of control (C) and exposed (prenatally-infected, E) day 0, 14, 35 developing mice. Note the increased density of GFAP-IR cells in the exposed brains (E).
Molecular Psychiatry
Cell counts were performed using the Micro-bright field stereo investigator software (Burlington, VT, USA). Generally, ependymal cells were identified by their location over the external surface of pia membrane and their intense black staining for GFAP ( Figure 1 ). All other cells positive for GFAP were localized to neocortical and hippocampal layers and stained strongly for GFAP and appeared stellate and with multiple processes (Figure 1 ). Cell counts were made in three areas, ie, ependymal lining, cortical layers I-VI and white matter and hippocampal layers, including the dentate gyrus.
The areas were measured using the Micro-bright field stereo investigator software and included cortex, hippocampus (including the dentate area) and total brain hemispere ( Figure 2 ). Measurements were made from three rostrocaudal areas of the brain approximating to the level of septodorsal hippocampus (level 1), mid septotemporal hippocampus (level 2), and temporoventral hippocampus (level 3). These measurements were obtained from a minimum of three sections per brain from control (n = 3 for each time group except n = 2 for postnatal day 35) and infected (n = 3 for each time group) mice. Mean areas in mm 2 ± SD (standard deviation) were obtained and subjected to statistical analysis.
Finally, cell density values for GFAP-positive neocortical and hippocampal compartments were obtained by dividing the cell count by mean of each area and expressed as cell counts per mm 2 ( Figure 2 ).
Statistical analysis
Statistical analysis of data was performed using SPSS V. 9 software (SPSS, Chicago, IL, USA) and consisted of two-way analyses of variance using prenatal viral infection exposure status (exposed vs control) and age (0, 14, 35 days) as between subject factors. Main effects and interaction effects were examined. Univariate comparisons were made using t-tests. Levene's test for equality of variance was used to determine if equality of variance could be assumed. When this was not the case, the t-test was adjusted to reflect this.
Results
Qualitative light microscopy GFAP-positive cells included both ependymal cells and astrocytes. In control brains, GFAP-positive ependymal cells were not numerous; moreover, GFAP-positive astrocytes were easily identifiable by a central round or ovoid cell body and multiple cellular processes ( Figure 1 ). In prenatally infected brains, more astrocytes and ependymal cells were present from birth to day 35 and included frequent hypertrophied cell bodies and increased cell branching (Figure 1 ). Numerous intensely-stained GFAP-positive cells were found in the hilus of dentate, molecular layer of hippocampus (especially near the hippocampal fissure), frontal, occipital, entorhinal and amygdaloid areas of neocortex ( Figure 1 ) in prenatally infected and less frequently in control brains (Figure 1 ). Brain and lung assays for evidence of CPE were negative in 6-week-old exposed mice. Moreover, no evidence of viral antigen was observed in 0, 14 and 35-day-old exposed brains.
GFAP-positive cell counts
There was a significant change in ependymal cell counts across days (F(2,42) = 6.91, P = 0.003). Specifically, counts were significantly higher on day 14 than on day 0 (t = −2.85, df = 33, P = 0.008) or day 35 (t = 2.36, df = 29, P = 0.025). Comparing groups, exposed mice had significantly higher ependymal cell counts (F(1,42) = 9.15, P = 0.004) when compared with control mice across time. Further analyses revealed significant differences between the groups on day 14 (t = 2.25, df = 16, P = 0.039) (Figure 2a ). In the cortical layers, counts changed significantly over time (F(2,43) = 10.19, P Ͻ 0.001). Specifically, both day 14 (t = −5.28, df = 18.52, P Ͻ 0.001) and day 35 (t = −3.59, df = 12.3, P = 0.004) values had higher counts than day 0. Comparing groups, values for exposed mice were significantly higher across the three time periods (F(1,43) = 9.45, P = 0.004); counts on day 14 were significantly higher for exposed mice (t = 2.30, df = 16, P = 0.035) with a trend in the same direction on day 35 (t = 1.84, df = 11, P = 0.093) (Figure 2b ). Across time, hippocampal cell counts changed significantly (F(2,43) = 16.19, P Ͻ 0.001). Specifically, hippocampal cell counts were significantly higher than day 0 on both day 14 (t = −6.53, df = 18.25, P Ͻ 0.001) and day 35 (t = −4.37, df = 12.18, P = 0.001). Comparing groups, hippocampal GFAP-positive cells were also significantly higher overall (F(1,43) = 14.76, P Ͻ 0.001) with a significant interaction between time and group (F(2,43) = 5.77, P = 0.006). Specifically, hippocampal cell counts in exposed mice were significantly higher than control mice on day 35 (t = 2.74, df = 11, P = 0.019) and trended higher on day 14 as well (t = 1.89, df = 16, P = 0.077) (Figure 2c ).
GFAP-positive cell densities
There was no significant change in cortical cell density over time. Comparing groups overall, cortical cell density was significantly higher for exposed mice (F(1,39) = 9.48, P = 0.004); with significant differences on day 14 (t = 2.30, df = 16, P = 0.031) (Figure 2d ). Across time hippocampal cell density changed significantly (F(2,39) = 5.99, P = 0.005). Specifically, both day 14 (t = −2.95, df = 27.15, P = 0.006) and day 35 (t = −2.94, df = 13.84, P = 0.011) were higher than day 0. Across groups, hippocampal cell density was also significantly higher overall for exposed as compared with control mice (F(1.39) = 15.34, P Ͻ 0.001). Significant differences were found on both day 14 (t = 2.31, df = 15, P = 0.035) and day 35 (t = 3.42, df = 8.41, P = 0.034) (Figure 2e ).
Brain area measurement
Cortical brain area changed significantly over time (F(2,39) = 59.1, P Ͻ 0.001). Specifically, cortical area for both day 14 (t = −14.63, df = 31, P Ͻ 0.001) and day 35 (t = −8.11, df = 12.3, P Ͻ 0.001) were greater than There are significant increases in exposed cortical (day 14, P = 0.031) and hippocampal (day 14, P = 0.035, day 35, P = 0.0334) values vs controls. Finally, the y-axis values for panels f-g represent cortical (f) and hippocampal (g) areas per brain hemisphere in mm 2 . Despite a parallel increase in brain area size in both groups, there are nonsignificant early decreases (day 0) and late increases (day 35) in cortical and hippocampal area measurements in the exposed mice. day 0. Hippocampal brain area also changed significantly over time (F(2,39) = 20.04, P Ͻ 0.001). Specifically, hippocampal area was greater on both day 14 (t = −7.32, df = 17.94, P Ͻ 0.001) and day 35 (t = −5.28, df = 11.72, P Ͻ 0.001) than day 0. Across groups, brain area did not differ significantly between exposed and control mice in either cortical or hippocampal layers.
Discussion
Prenatal human influenza viral infection on day 9 of pregnancy caused time-dependent alterations in GFAP immunoreactivity of astrocytes and ependymal cells in brains of P0, P14 and P35-day-old mice. Ependymal cell GFAP immunoreactivity dropped from a high on P0 to lower levels by day 35 in both control and experimental animals. However, exposed animals showed a significant increase in ependymal GFAP immunoreactivity at day 14 (P = 0.039) and a nonsignificant rise at 35 days when compared to controls. In contrast, the time course of GFAP expression in brain astrocytes showed a parallel time-dependent rise from day 0 to day 35 in both groups. In the exposed mouse brains, astrocyte GFAP staining expressed as cell counts showed significant elevations in 14-day cortex (P = 0.035) and 35-day hippocampus (P = 0.019) when compared to respective age-matched control animals.
Glial fibrillary acidic protein is a 50 kDa 15 major protein of astrocyte intermediate filaments and a specific marker for astrocytes. 16, 17 GFAP production begins as early as 25 weeks in normal human astrocytes 18 and as early as 15 weeks in ependymal cells following brain damage in utero. 19, 20 In the murine brain, GFAP staining of astrocytes appears on embryonic day 18 to P0 with a subsequent rise by 2 weeks and later plateau by 1 month. Astrocytes bearing GFAP immunoreactivity serve many functions in health and disease including guidance of neuronal migration, production of extracellular matrix proteins and adhesion molecules, 21, 22 production of neurite promoting factors, cerebral angiogenesis, neurotransmission, regulation of pH and ion concentration, phagocytosis, glutathione production and neuroendocrine functions. 17 More recently, astrocytes have been implicated in metabolic roles such as uptake of glucose and glutamate, storage of glycogen and clearance of potassium. Additionally, D'Ambrosio et al (1998) showed the presence of three functionally distinct hippocampal astrocytes which maintain the normal excitability of cells in hippocampus. 23 Following CNS injury, GFAP expression and protein synthesis rise rapidly denoting brain reaction to insult. 24 A large body of information indicates that GFAP production is an important marker of CNS injury. Pre-and postnatal viral infections including mumps and influenza, 25, 26 LP-BM5 leukemia virus,
27
A59 mouse hepatitis 28, 29 and HIV 30, 31 cause significant astrogliosis, demonstrated by increased GFAP expression, astrocytic hypertrophy and hyperplasia. Our data are supported by various reports showing a sustained increase in GFAP protein production up to 2 months following viral insult to the developing brain. 27, 30 Increased GFAP production by astrocytes is a nonspecific indicator of injury since other types of injury such as lithium administration, 32 and trimethyltene exposure, 15, 60 CO irradiation 33 and 6-OHDA and MPTP lesioning 34 may cause astrogliosis. Recent evidence supports the contention that abnormalities of astrocytic function may affect corticogenesis. 35 In ␣3 integrin mutant mice, GFAP production begins earlier during brain development causing perturbations in the normal schedule of neuron migration in association with radial glial fibers. 35 These mice also suffer from defective cortical lamination and abnormal neuronal migration. This is similar to findings of reduced Reelin and defective corticogenesis observed in our exposed mice. Early embryonic exposure of day 9 mouse embryos to Human Influenza Virus clearly increased the GFAP immunoreactivity in the ependymal layer on day 0 with a subsequent rise in brain astrocytic GFAP on postnatal days 14 and 35. This early rise in ependymal cell GFAP production may be secondary to stimulation of ependymal cells either directly by maternal viral antigen (less likely here, since no viral antigen was detected in exposed mice) or via cytokine production from maternal, placental or fetal sources. Indeed neurotropic human influenza A virus (WSN strain) which is similar to the strain used by us has an high affinity to ependymal cells and causes significant damage to these cells. 26 Mumps virus also appears to have a predilection toward ependymal cells. 25 Ependymal cell GFAP immunoreactivity disappears by adulthood in man. 20 In our study, normal brain ependymal GFAP immunoreactivity decreased on day 35 postnatally. The same pattern was also seen in experimental animals where ependymal GFAP-IR declined by 65% on day 35. This pattern may also indicate that the timing of appearance of ependymal GFAP-IR in mouse brain follows a rigid developmental pattern.
Astrocytic GFAP cell density in cerebral cortex of normal mice reached a peak on postnatal day 14 and later fell by day 35. A similar trend was also seen in normal hippocampus. Prenatal infection with human influenza virus on day 9 of pregnancy caused significant increases in GFAP cell density in hippocampus on days 14 and 35 (P = 0.034, P = 0.035 respectively) and in cerebral cortex (day 14, P = 0.031) vs controls. The sustained GFAP rise in exposed brains is probably due to either presence of stimulating cytokines or an enhanced programming of GFAP synthetic machinery due to reduced production of Reelin in day 0 exposed mice. Another interesting finding in our study is the early decrease in brain area on day 0 of birth with a later rise in brain area in day 35 infected brains. The later increase in brain area may be due to increased production of pyramidal cells (Fatemi et al, submitted) . It is conceivable that increased gliogenesis and abnormal corticogenesis due to Reelin deficiency or increased cytokine production may result in increased brain mass.
Our findings give further credence to a significant body of literature pointing to an association between prenatal viral infection and subsequent rise in inci-dence of schizophrenia, 4 autism 36 and cerebral palsy. 37 Studies dealing with postmortem brains of schizophrenic individuals generally discount the role of gliosis in the etiology of this disorder. 10, [38] [39] [40] However, in at least one group of schizophrenic patients, increased GFAP and gliosis has been reported. 11 Moreover Stevens et al 41 and Bruton et al 12 have reported on periventricular gliosis especially in diencephalon of schizophrenics which is reminiscent of the increased GFAP-IR in the prenatally infected mouse brains, localized in proximity to cerebral cortical periventricular space and hippocampal fissure (Figure 1) . A more recent report also showed hypertrophy and more intensive GFAP reaction in astrocytes of olfactory tubercle in schizophrenic subjects. 42 Since glial reaction to injury may eventually disappear after months or years, absence of overt gliosis in brains of adult schizophrenics is not surprising. However, recent data indicate that other indices of inflammation/ infection such as cytokine levels may be elevated in schizophrenic and autistic blood and CSF samples. 43 Thus absence of gliosis alone should not be construed as absence of neuroimmunologic dysfunction. A recent report 44 demonstrated significant increases in density of HLA-DR+ microglia in temporal and frontal cortices of schizophrenics independent of the aging process, as well as a nonsignificant trend for increased astroglial numerical density in schizophrenic brains. Finally, our previous work on abnormal expression of several other synaptic markers in day 0 prenatally infected brains tends to support an intimate link between neuronal and glial dysfunction in this model. Indeed, elevations in SNAP-25 and nNOS IR in infected hippocampi 7, 8 as well as GFAP may signify an important pathologic process at work here. Patanow et al 15 also showed increases in SNAP-25 and GFAP in hippocampi of rat brains following transection of the fimbria-fornix and perforant pathways or after selective neurotoxicant trimethylin exposure. Kainate treatment also increased NADPHdiaphorase staining in astrocytes, 45 suggesting the involvement of nitric oxide in this type of pathology. The reported histologic abnormalities in cortex of infected day 0 mice may be partially explained by an abnormal neurodevelopmental mechanism where reduced Reelin production 9 as well as premature astrogliosis combine to disrupt the normal process of corticogenesis.
Indeed mutation of ␣3 integrin protein 35 a potential receptor for Reelin 46 molecule may cause premature astrogliosis and subsequent abnormal corticogenesis in mutant mice.
In conclusion, we have provided experimental evidence to support a direct link between prenatal human influenza viral infection and subsequent astroglial and ependymal reaction which is present and sustained from postnatal day 0 to days 14 and 35 and may either be responsible for, or a consequence of, pathology in several other brain markers important during brain development. This study further supports the contention that at least certain cases of schizophrenia, autism and cerebral palsy may be due to viral insults in utero.
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